Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome

Protein Science

Volumn 5, Issue 3, 1996, Pages 531-534

  Bajorath, Jürgen ^a,c   Seyama, Kuniaki ^b   Nonoyama, Shigeaki ^d   Ochs, Hans D ^b   Aruffo, Alejandro ^a,c  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

CD40 ligand; molecular model; natural mutations; receptor ligand interactions; structure function analysis; X linked hyper IgM syndrome

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN; IMMUNOGLOBULIN M; MUTANT PROTEIN;

ANTIGEN BINDING; ARTICLE; GENE MUTATION; HUMAN; HYPERIMMUNOGLOBULINEMIA; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION;

EID: 0029927640     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560050316     Document Type: Article

References (34)

1. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, Fanslow WC, Belmont J, Spriggs MK. 1993. CD40 ligand gene defects responsible for X-linked hyper IgM syndrome. Science 259:990-993.
2. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D, Spriggs MK. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357:80-82.
3. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper IgM syndrome. Cell 72:291-300.
4. Aruffo A, Hollenbaugh D, Wu L, Ochs HD. 1994. The molecular basis of agammaglobulinemia, X-linked hyper IgM syndrome, and severe combined immunodeficiency in humans. Curr Opin Hematol 1:12-18.
5. Bajorath J, Chalupny NJ, Marken JS, Siadak AW, Skonier J, Gordon M, Hollenbaugh D, Noelle RJ, Ochs HD, Aruffo A. 1995a. Identification of residues on CD40 and its ligand which are critical for receptor-ligand interactions. Biochemistry 34:1833-1844.
6. Bajorath J, Marken JS, Chalupny NJ, Spoon TL, Siadak AW, Gordon M, Noelle RJ, Hollenbaugh D, Aruffo A. 1995b. Analysis of gp39/CD40 interactions using molecular models and site directed mutagenesis. Biochemistry 34:9884-9892.
7. Bajorath J, Stenkamp R, Aruffo A. 1993. Knowledge-based model building of proteins: Concepts and examples. Protein Sci 2:317-334.
8. Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W. 1993 Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation. Cell 73:431-445.
9. Beutler B, van Huffel C. 1994. Unraveling function in the TNF ligand and receptor families. Science 254:667-668.
10. Di Santo JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint-Basile G. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361:541-543.
11. Durandy A, Schiff C, Bonnefoy JY, Forveille M, Roussel F, Mazzei G, Milili M, Fischer A. 1993. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome. Eur J Immunol 23:2294-2299.
12. Eck MJ, Sprang SR. 1989. The structure of tumor necrosis factor at 2.6 Å resolution: Implications for receptor binding. J Biol Chem 264:17595-17606.
13. Eck MJ, Ultsch M, Rinderknecht E, de Vos AM, Sprang SR. 1992. The structure of human lymphotoxin (tumor necrosis factor-β) at 1.9 Å resolution. J Biol Chem 267:2119-2122.
14. Farrah T, Smith CA. 1992. Emerging cytokine family. Nature 358:16.
15. Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, Fu SM, Stamenkovic I, Geha RS. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 90:2170-2173.
16. Graf D, Korthauer U, Mages HW, Senger G, Kroczek RA. 1992. Cloning of TRAP, a ligand for CD40 on human B cells. Eur J Immunol 22:3191-3194,
17. Hermann P, Blanchard D, de Saint-Vis B, Fossiez F, Gaillard C, Vanbervliet B, Briere F, Banchereau J, Galizzi JP. 1993. Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes. Eur J Immunol 23:961-964.
18. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11:4313-4321.
19. Hollenbaugh D, Ochs HD, Noelle RJ, Ledbetter JA, Aruffo A. 1994. The role of CD40 and its ligand in the regulation of the immune response. In: Möller G, ed. Immunological reviews. Copenhagen. International Publishers, Ltd. pp 1-37.
20. Jones EY, Stuart DI, Walker NPC. 1989. Structure of tumor necrosis factor. Nature 335:225-228.
21. Karpusas M, Hsu YM, Wang JH, Thompson J, Lederman S, Chess L, Thomas D. 1995. 2 Å crystal structure of an extracellular fragment of human CD40 ligand. Structure 3:1031-1039.
22. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539-541.
23. Lane P, Traunecker A, Hubele S, Inui S, Lanzaveccia A, Gray D. 1992. Activated human T celis express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 22:2573-2578.
24. Lederman S, Yellin MJ, Cleary AM, Pernis A, Inghirami G, Cohn LE, Covey LR, Lee JJ, Rothman P, Chess L. 1994. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol 152:2163-2171.
25. Lee BK, Richards FM. 1971. The interpretation of protein structures: Estimation of static accessibility. J Mol Biol 55:379-400.
26. Macchi P, Villa A, Strina D, Sacco MG, Morali F, Brugnoni D, Giliani S, Mantuano E, Fasth A, Andersson B, Zegers BJM, Cavagni G, Reznick I, Levy J, Zan-Bar I, Porat Y, Airo P, Plebani A, Vezzoni P, Notarangelo LD. 1995. Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry. Am J Hum Genet 55:898-906.
27. Noelle RJ, Ledbetter JA, Aruffo A. 1992a. CD40 and its ligand are an essential ligand-receptor pair for thymus-dependent B cell activation. Immunol Today 13:431-433.
28. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A. 1992b. A 39 kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 89:6550-6554.
29. Peitsch MC, Jongeneel CV. 1993. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to tumor necrosis factor. Int Immunol 5:233-238.
30. Ramesh N, Fuleihan R, Ramesh V, Lederman S, Yellin MJ, Sharma S, Chess L, Rosen FS, Geha RS. 1993. Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Int Immunol 5:769-773.
31. Saiki O, Tanaka T, Wada Y, Uda H, Inoue A, Katada Y, Izeki M, Iwata M, Nunoi H, Matsuda I, Kinoshita N, Kishimoto T. 1995. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM. J Clin Invest 95:510-514.
32. Smith CA, Farrah T, Goodwin RG. 1994. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 70:959-962.
33. Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC. 1992 Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176:1543-1550.
34. Villa A, Notarangelo LD, Di Santo JP, Macchi PP, Strina D, Frattini A, Lucchini F, Patrosso CM, Giliani S, Mantuano E, Agosti S, Nocera G, Kroczek RA, Fischer A, Ugazio AG, De Saint Basile G, Vezzoni P. 1994. Organization of the human CD40L gene: Implications for molecular defects in X chromosome-linked hyper IgM syndrome and prenatal diagnosis. Proc Natl Acad Sci USA 91:2110-2114.